{"id":71400,"date":"2026-05-20T09:01:36","date_gmt":"2026-05-20T09:01:36","guid":{"rendered":"https:\/\/medsbase.com\/pinealon\/"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"pinealon","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-br\/product\/pinealon\/","title":{"rendered":"Pinealon"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 Pinealon?<\/h3>\n<p style=\"margin: 0;\"><strong>Pinealon<\/strong> is a synthetic tripeptide (sequence Glu-Asp-Arg, EDR) belonging to the Khavinson short-peptide bioregulator family developed at the St. Petersburg Institute of Bioregulation and Gerontology. Originally derived from cattle pineal-gland-extract studies, Pinealon is studied for neuroprotective, anti-oxidant, and cognitive-aging effects in clinical models \u2014 with a proposed mechanism involving direct nuclear access and chromatin-level gene-expression regulation. Sibling peptide to <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> within the Khavinson series. Supplied in 5 mg, 10 mg, and 20 mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que voc\u00ea obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-br\/reviews\/\">\ud83d\udce6 Cada pedido \u00e9 coberto pela nossa<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Todo pedido \u00e9 coberto pelo nosso <a href=\"https:\/\/medsbase.com\/pt-br\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Reenvio Garantido<\/strong><\/a> \u2014 se sua encomenda n\u00e3o chegar em 20 dias \u00fateis, n\u00f3s a reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">308067-43-8 (comumente citado; nem todas as fontes de pept\u00eddeos publicam um n\u00famero de registro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Tipo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Synthetic tripeptide bioregulator (Khavinson short-peptide family) \u2014 developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson; originally based on cattle pineal-gland extract studies. Pinealon is the cognitive \/ neuroprotective member of the Khavinson series, paired with <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (longevidade\/telomerase) como os dois compostos mais estudados.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>15<\/sub>H<sub>26<\/sub>N<sub>6<\/sub>O<sub>8<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~418,4 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">H-Glu-Asp-Arg-OH (EDR) \u2014 sequ\u00eancia linear de 3 res\u00edduos. Termina\u00e7\u00f5es N e C livres; sem ponte dissulfeto, sem acila\u00e7\u00e3o, sem PEGila\u00e7\u00e3o. Carga l\u00edquida +1 em pH neutro (um Arg cati\u00f4nico equilibrado contra os grupos carboxilato de Glu\/Asp).<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (branco a branco amarelado)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA sob solicita\u00e7\u00e3o)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (geladeira) para estoque de trabalho; \u221220 \u00b0C para armazenamento de longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, use dentro de ~14\u201328 dias. Proteger da luz. Evite ciclos repetidos de congelamento-descongelamento da solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Altamente sol\u00favel em \u00e1gua bacteriost\u00e1tica ou \u00e1gua est\u00e9ril \u2014 tripept\u00eddeos carregados dissolvem-se rapidamente com agita\u00e7\u00e3o suave. N\u00e3o s\u00e3o necess\u00e1rios solventes especializados.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 Pinealon?<\/h2>\n<p><strong>Pinealon<\/strong> is a synthetic tripeptide consisting of L-glutamic acid, L-aspartic acid, and L-arginine (sequence Glu-Asp-Arg, single-letter code EDR). It is a member of the Khavinson short-peptide bioregulator family \u2014 a group of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson, originally based on the fractionation and characterisation of bioactive material extracted from cattle pineal gland and other tissues. Within the Khavinson series, Pinealon is the compound most associated with cognitive function and neuroprotection in published studies, while its sibling tetrapeptide <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (Ala-Glu-Asp-Gly, AEDG) is the most-studied compound in the longevity \/ telomerase context. Khavinson short peptides differ structurally from most other peptides in two important ways: <strong>eles s\u00e3o extremamente curtos<\/strong> (Pinealon \u00e9 composto por apenas tr\u00eas res\u00edduos, MW ~418 Da, menor que uma mol\u00e9cula pequena t\u00edpica) e <strong>seu mecanismo proposto centra-se no acesso nuclear direto<\/strong> rather than receptor binding at the plasma membrane. The published Khavinson model holds that short charged peptides can cross both the cell membrane and the nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific interactions with DNA \u2014 a mechanism distinct from the canonical receptor-binding pharmacology of larger peptides. This model is supported by published studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. Pinealon has been investigated in clinical contexts focused on cognitive aging, oxidative-stress protection of neuronal cultures, cerebral ischemia models, and circadian \/ pineal-axis studies. It is <strong>n\u00e3o aprovado<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Bioregula\u00e7\u00e3o por Pept\u00eddeos Curtos de Khavinson<\/h2>\n<p>The published mechanistic model for Khavinson short peptides \u2014 supported by studies from the Khavinson group and tested in independent laboratories \u2014 proposes three principal modes of action:<\/p>\n<ul>\n<li><strong>Acesso nuclear direto e regula\u00e7\u00e3o da express\u00e3o g\u00eanica por liga\u00e7\u00e3o ao DNA<\/strong> \u2014 Os pept\u00eddeos curtos de Khavinson s\u00e3o propostos a atravessar a membrana plasm\u00e1tica e o envelope nuclear e alcan\u00e7ar a cromatina diretamente. O modelo publicado sustenta que as sequ\u00eancias curtas carregadas (tipicamente contendo combina\u00e7\u00f5es de res\u00edduos de Glu\/Asp\/Arg\/Lys) podem se envolver em contatos espec\u00edficos de sequ\u00eancia com o sulco maior ou menor do DNA em forma B nas regi\u00f5es promotoras, modulando a transcri\u00e7\u00e3o de pain\u00e9is espec\u00edficos de genes. Pinealon (Glu-Asp-Arg) foi associado em trabalhos publicados \u00e0 regula\u00e7\u00e3o positiva de genes envolvidos na defesa antioxidante, fun\u00e7\u00e3o mitocondrial e sobreviv\u00eancia neuronal.<\/li>\n<li><strong>Efeitos antioxidantes e de prote\u00e7\u00e3o mitocondrial<\/strong> \u2014 Em modelos de cultura neuronal e in vivo em roedores, a administra\u00e7\u00e3o de Pinealon \u00e9 relatada para reduzir marcadores de esp\u00e9cies reativas de oxig\u00eanio (ROS), preservar o potencial de membrana mitocondrial sob estresse (hiper\u00f3xia, hip\u00f3xia, excitotoxicidade por glutamato) e diminuir a sinaliza\u00e7\u00e3o apopt\u00f3tica. Esses efeitos s\u00e3o consequ\u00eancia da modula\u00e7\u00e3o da express\u00e3o g\u00eanica, e n\u00e3o da elimina\u00e7\u00e3o direta de radicais.<\/li>\n<li><strong>Neuroprote\u00e7\u00e3o em modelos de envelhecimento cognitivo<\/strong> \u2014 Estudos comportamentais em roedores idosos relataram melhorias no desempenho de aprendizagem espacial e mem\u00f3ria de trabalho ap\u00f3s a administra\u00e7\u00e3o de Pinealon em compara\u00e7\u00e3o com controles da mesma idade. O mecanismo \u00e9 interpretado como uma combina\u00e7\u00e3o de prote\u00e7\u00e3o antioxidante de popula\u00e7\u00f5es neuronais vulner\u00e1veis (hipocampo CA1, camada cortical V) e efeitos diretos na express\u00e3o g\u00eanica em neur\u00f4nios que suportam a maquinaria de plasticidade sin\u00e1ptica.<\/li>\n<\/ul>\n<p>Khavinson short peptides have very short plasma half-lives (minutes), but proposed effects persist for hours to days through downstream gene-expression cascades \u2014 a profile broadly similar to other receptor-trigger peptides where duration is set by signalling-cascade kinetics rather than by sustained plasma residence. Subcutaneous administration is the standard route in published studies protocols. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Pinealon is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Cognitive-aging studies<\/strong> \u2014 spatial learning, working memory, and behavioural performance in aged-rodent models; the most-studied application for Pinealon<\/li>\n<li><strong>Prote\u00e7\u00e3o contra estresse oxidativo em culturas neuronais<\/strong> \u2014 prote\u00e7\u00e3o de culturas prim\u00e1rias corticais e hipocampais contra H<sub>2<\/sub>O<sub>2<\/sub>, excitotoxicidade por glutamato, hiper\u00f3xia; leituras de ERO e potencial de membrana mitocondrial<\/li>\n<li><strong>Modelos de isquemia cerebral \/ AVC<\/strong> \u2014 les\u00e3o por isquemia-reperfus\u00e3o em modelos de oclus\u00e3o da art\u00e9ria cerebral m\u00e9dia (MCAO) em roedores; resultados de volume de infarto e d\u00e9ficits comportamentais<\/li>\n<li><strong>Neurodegenerative-disease in-vitro studies<\/strong> \u2014 Modelos de toxicidade do tipo A\u03b2 de Alzheimer e toxicidade do tipo \u03b1-sinucle\u00edna de Parkinson em neur\u00f4nios cultivados; trabalho publicado em linhagens PC12 e SH-SY5Y<\/li>\n<li><strong>Hypoxia and high-altitude studies<\/strong> Pesquisa sobre o eixo pineal e ritmo circadiano<\/li>\n<li><strong>Pineal-axis and circadian rhythm support<\/strong> \u2014 historical pineal-gland-extract origin makes Pinealon a tool for examining pineal-axis modulation of circadian gene expression, though most current studies focuses on neuroprotection rather than circadian rhythm per se<\/li>\n<li><strong>Farmacologia comparativa dos pept\u00eddeos Khavinson<\/strong> \u2014 compara\u00e7\u00e3o lado a lado com <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (AEDG, longevidade\/telomerase), Vilon (KE, imunidade) e Livagen (KEDA, hepatoprote\u00e7\u00e3o) para dissecar a especificidade sequencial dos efeitos dos pept\u00eddeos curtos<\/li>\n<\/ul>\n<p>For broader context on neuroactive short peptides and related compounds, see <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (tetrapept\u00eddeo Khavinson relacionado), <a href=\"https:\/\/medsbase.com\/pt-br\/semax\/\">Semax<\/a> (heptapept\u00eddeo derivado de ACTH, aprimoramento cognitivo), <a href=\"https:\/\/medsbase.com\/pt-br\/selank\/\">Selank<\/a> (ansiol\u00edtico\/nootr\u00f3pico derivado de tuftsina) e <a href=\"https:\/\/medsbase.com\/pt-br\/dsip\/\">DSIP<\/a> (pept\u00eddeo indutor do sono delta). Navegue pelo <a href=\"https:\/\/medsbase.com\/pt-br\/peptides\/\">cat\u00e1logo de pept\u00eddeos<\/a> para compostos relacionados. <\/p>\n<h2>Concentra\u00e7\u00f5es e Dosagens Dispon\u00edveis<\/h2>\n<p>MedsBase stocks Pinealon in three lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosagem do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de Uso T\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos de Embalagem<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dosagem piloto \u2014 protocolos curtos para envelhecimento cognitivo, titula\u00e7\u00e3o de dose-resposta, trabalho in-vitro de estresse oxidativo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength \u2014 multi-week cognitive-aging studies, MCAO ischemia models, multi-cohort protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>20 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Protocolos de ciclo estendido \u2014 estudos de envelhecimento de longo prazo, trabalhos comportamentais de grande coorte, menor custo por mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 ou 30 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, \u226599% HPLC purity). Published studies protocols use a wide dose range depending on model and route \u2014 typically 100 \u00b5g\u20134 mg per kg body weight in rodent models. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h2>Como Comparar \u2014 Pinealon vs Epitalon<\/h2>\n<p>Pinealon e <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> are the two most-studied compounds in the Khavinson short-peptide family. Both are short charged peptides developed by the same group and share the proposed direct-nuclear-access mechanism, but they have entirely different sequence specificity and different best-studied applications. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Pinealon<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Epitalon<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Glu-Asp-Arg (EDR)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ala-Glu-Asp-Gly (AEDG)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Comprimento<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">3 amino\u00e1cidos (tripept\u00eddeo)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">4 amino\u00e1cidos (tetrapept\u00eddeo)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~418 Da<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~390 Da<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Carga l\u00edquida<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">+1 (Arg equilibra Glu\/Asp)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u22122 (Glu\/Asp dominam; sem res\u00edduos cati\u00f4nicos)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Best-studied studies focus<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Envelhecimento cognitivo, neuroprote\u00e7\u00e3o, prote\u00e7\u00e3o contra estresse oxidativo em culturas neuronais<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Telomerase activation, lifespan extension, longevity studies<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Origem do tecido (proposta)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fracionamento de extrato de gl\u00e2ndula pineal bovina<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Fracionamento de extrato de gl\u00e2ndula pineal bovina<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo proposto<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acesso nuclear direto; modula\u00e7\u00e3o antioxidante e da express\u00e3o g\u00eanica mitocondrial<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Acesso nuclear direto; liga\u00e7\u00e3o proposta ao promotor da telomerase<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Meia-vida plasm\u00e1tica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutos (o efeito persiste por meio de cascatas subsequentes)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Minutos (o efeito persiste por meio de cascatas subsequentes)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For studies focused on neuroprotection, cognitive-aging models, or oxidative-stress protection of neuronal cultures, Pinealon is the more targeted Khavinson peptide. For studies focused on telomerase activation, replicative-senescence reversal, or longevity-axis pharmacology, <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> remains the more widely-studied option. Some protocols use both compounds in parallel to dissect the sequence-specificity of Khavinson short-peptide effects. <\/p>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 14px 18px; margin: 18px 0;\"><strong class=\"mb-bac-water-callout\">\ud83d\udca7 Precisa de \u00e1gua BAC?<\/strong> A reconstitui\u00e7\u00e3o de qualquer frasco liofilizado requer \u00e1gua bacteriost\u00e1tica est\u00e9ril. Combine este produto com nosso <a href=\"\/pt-br\/bac-water\/\"><strong>\u00c1gua BAC (\u00c1gua Bacteriost\u00e1tica)<\/strong><\/a> \u2014 frasco multidose de 30 mL, preservado com 0,9% de \u00e1lcool benz\u00edlico, grau USP.<\/div>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazene frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para estoque de trabalho de curto prazo. Para armazenamento de longo prazo, congele frascos fechados a \u221220 \u00b0C. O Pinealon liofilizado \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220 \u00b0C por at\u00e9 36 meses. Evite ciclos de congelamento e descongelamento no p\u00f3 liofilizado. O Pinealon \u00e9 um tripept\u00eddeo curto n\u00e3o modificado sem ponte dissulfeto ou cadeia acil \u2014 o manuseio est\u00e1 entre os mais simples do cat\u00e1logo. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injete \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado). Para um frasco de 10 mg, 2,0 mL de \u00e1gua bacteriost\u00e1tica produzem uma concentra\u00e7\u00e3o de trabalho de 5 mg\/mL; 1,0 mL produz um estoque de 10 mg\/mL. Para um frasco de 5 mg, 1,0 mL de \u00e1gua bacteriost\u00e1tica produz um estoque de trabalho de 5 mg\/mL. Para um frasco de 20 mg, 2,0 mL produzem um estoque de trabalho de 10 mg\/mL. Agite suavemente \u2014 n\u00e3o agite vigorosamente, pois a espuma aprisiona ar e pode perturbar as cadeias pept\u00eddicas. Deixe o p\u00f3 dissolver completamente (geralmente &lt;1 minuto para o Pinealon) antes de retirar. Uma vez reconstitu\u00eddo, armazene o frasco a 2\u20138 \u00b0C e use dentro de 14\u201328 dias. Proteja da luz. Descarte se aparecer turva\u00e7\u00e3o, part\u00edculas ou mudan\u00e7a de cor. <\/p>\n<h2>Perguntas Frequentes<\/h2>\n<h3>O que \u00e9 a fam\u00edlia de pept\u00eddeos curtos de Khavinson e por que o Pinealon faz parte dela?<\/h3>\n<p>The Khavinson short-peptide family is a series of 2- to 4-amino-acid peptides developed at the St. Petersburg Institute of Bioregulation and Gerontology by Vladimir Khavinson and colleagues, starting in the 1970s. The original studies extracted bioactive material from various cattle tissues (pineal, thymus, prostate, retina, etc.) and identified short peptide fragments responsible for tissue-specific bioregulatory effects. Pinealon (Glu-Asp-Arg) is the cognitive \/ neuroprotective compound in this series; <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (Ala-Glu-Asp-Gly) \u00e9 o composto de longevidade\/ativa\u00e7\u00e3o da telomerase; Vilon, Livagen, Thymogen e outros t\u00eam como alvo outros tecidos. <\/p>\n<h3>Como o Pinealon difere do Epitalon?<\/h3>\n<p>Both are short Khavinson peptides extracted from cattle pineal-gland studies, but they have different sequences and different best-studied applications. Pinealon (Glu-Asp-Arg, tripeptide, +1 net charge) is studied for cognitive aging and neuroprotection. <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (Ala-Glu-Asp-Gly, tetrapept\u00eddeo, carga l\u00edquida \u22122) \u00e9 estudado para ativa\u00e7\u00e3o da telomerase e extens\u00e3o da vida \u00fatil. A carga l\u00edquida oposta \u00e9 uma raz\u00e3o estrutural pela qual os dois pept\u00eddeos t\u00eam como alvo diferentes loci gen\u00f4micos sob o mecanismo proposto de liga\u00e7\u00e3o direta ao DNA. <\/p>\n<h3>Qual \u00e9 o mecanismo proposto dos pept\u00eddeos curtos de Khavinson?<\/h3>\n<p>The published Khavinson model holds that short charged peptides can cross the cell membrane and nuclear envelope, reach chromatin, and modulate gene expression through sequence-specific contacts with the DNA double helix at promoter regions. This is distinct from the canonical receptor-binding mechanism of larger peptides. The model is supported by studies from the Khavinson group spanning several decades and is the subject of continued mechanistic investigation by independent users. <\/p>\n<h3>Qu\u00e3o curto pode ser um pept\u00eddeo e ainda ser biologicamente ativo?<\/h3>\n<p>Pinealon at 3 amino acids is among the shortest pharmacologically-active peptides known. Even shorter examples exist (the dipeptide carnosine, the GLP-1 fragments, dipeptide HSP modulators), but most peptides are longer (10\u201340+ residues). The Khavinson short-peptide series is a focused area of studies specifically because the very short sequences allow rapid synthesis, easy crossing of cellular barriers, and clean structure-activity dissection. <\/p>\n<h3>Por que a meia-vida plasm\u00e1tica do Pinealon \u00e9 t\u00e3o curta?<\/h3>\n<p>Pept\u00eddeos curtos carregados s\u00e3o rapidamente eliminados por filtra\u00e7\u00e3o glomerular e prote\u00f3lise. O Pinealon tem meia-vida plasm\u00e1tica de apenas minutos \u2014 por\u00e9m, os efeitos propostos (modula\u00e7\u00e3o da express\u00e3o g\u00eanica, prote\u00e7\u00e3o antioxidante, melhora comportamental) persistem por horas a dias atrav\u00e9s de cascatas de sinaliza\u00e7\u00e3o a jusante. Esse perfil \u00e9 semelhante a outros pept\u00eddeos desencadeadores de receptores, onde a dura\u00e7\u00e3o \u00e9 determinada pela cin\u00e9tica da cascata de sinaliza\u00e7\u00e3o, n\u00e3o pela perman\u00eancia plasm\u00e1tica sustentada. <\/p>\n<h3>What is the typical dose of Pinealon in rodent models?<\/h3>\n<p>Published rodent-model dose ranges span approximately 100 \u00b5g\u20134 mg per kg body weight per day, depending on route (subcutaneous most common), model (cognitive aging, MCAO, oxidative stress), and study duration. Subcutaneous administration is the standard administration route. Determine dose ranges from peer-reviewed literature appropriate to your specific protocol. <\/p>\n<h3>O Pinealon tem efeitos fora do SNC?<\/h3>\n<p>Pinealon is best-studied in CNS contexts (cognitive aging, neuroprotection, cerebral ischemia), but the proposed mechanism \u2014 direct nuclear access and gene-expression modulation \u2014 is in principle tissue-independent. Some published studies has examined peripheral effects (anti-oxidant in hepatic and renal models, immunomodulation in mixed-cell-culture systems), but the bulk of the literature centres on CNS readouts. <\/p>\n<h3>Existe documenta\u00e7\u00e3o estabelecida de n\u00famero de registro CAS para o Pinealon?<\/h3>\n<p>O CAS 308067-43-8 \u00e9 o n\u00famero de registro mais comumente citado em cat\u00e1logos de fornecedores de pept\u00eddeos, mas diferentemente <a href=\"https:\/\/medsbase.com\/pt-br\/epitalon\/\">Epitalon<\/a> (which has a well-documented CAS 307297-39-8 across major reference databases), Pinealon&#8217;s CAS registration is less authoritatively published. Users requiring a regulatory-grade authoritative reference should verify against current CAS Registry sources. <!-- medsbase-related-alts-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Bioregulador de pept\u00eddeo curto de Khavinson (tripept\u00eddeo EDR)<br \/>\n\u2705 Proposto acesso nuclear direto + sinaliza\u00e7\u00e3o em n\u00edvel de cromatina<br \/>\n\u2705 Estudado em modelos de envelhecimento cognitivo e neuroprote\u00e7\u00e3o<br \/>\n\u2705 Antioxidante + protetor mitocondrial em culturas neuronais<br \/>\n\u2705 Irm\u00e3o do Epitalon (pept\u00eddeo da longevidade)<\/p>\n<p><strong>Pinealon<\/strong> cont\u00e9m composto de pept\u00eddeo sint\u00e9tico.<\/p>","protected":false},"featured_media":71407,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6468,6467,5441,6466],"class_list":["post-71400","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-edr","product_tag-khavinson","product_tag-peptide","product_tag-pinealon","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product\/71400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/comments?post=71400"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media\/71407"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/media?parent=71400"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_brand?post=71400"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_cat?post=71400"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-br\/wp-json\/wp\/v2\/product_tag?post=71400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}